NCT05027503Completed
Effectiveness of the Hippotherapy Simulator in Children and Adolescents with Cystic Fibrosis
Investigation of the Effectiveness of the Hippotherapy Simulator Added to Respiratory Physiotherapy in Children and Adolescents with Cystic Fibrosis
Source: ClinicalTrials.gov · Last updated 5 Feb 2025
Brief summary (registry, in English)
Cystic fibrosis (CF) is a genetic disease that affects many organs and systems, especially respiratory system problems due to lung damage. Patients often have difficulty in removing the sticky and viscous secretion that accumulates in the respiratory tract, and the risk of mortality increases with the development of respiratory failure. In patients with CF, exercise capacity, peripheral muscle strength, core endurance, flexibility, postural stability, physical activity level, and quality of life also decrease secondarily. Recently published guidelines recommend respiratory physiotherapy for coping with CF-related symptoms and recommend referral of patients to physical activity and exercise. Hippotherapy simulator is a mechanical exercise tool that imitates the walking movement of a real horse and is used to increase physical fitness parameters. This study aims to show the effects of exercises performed with a hippotherapy simulator in addition to respiratory physiotherapy on physical fitness, sputum production, physical activity and quality of life of children with CF.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 19 Aug 2021
- Start date
- 19 Dec 2021
- Primary completion date
- 19 Feb 2024
- Lead sponsor
- Istanbul University - Cerrahpasa
- Diseases
- Cystic fibrosis
- NCT number
- NCT05027503
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 19 Dec 2021 to the primary completion date, 19 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of previous lung or liver transplant
Other illness
- History of diagnosed orthopedic problems affecting mobility or musculoskeletal surgery
- History of hospitalization in the last 1 month
Other
- Contracture or deformity,
- Have diagnosed vision, hearing, vestibular or neurological problems that may affect balance,
- Patients who have participated in any exercise training program in the last 6 months
Who the study is looking for
- Be in the 8-14 age range
- To be diagnosed with cystic fibrosis according to the American Cystic Fibrosis Association consensus report criteria
- Having mild (FEV1 ≥ 70% predictive) lung disease according to the disease severity classification in the annual report of the American Cystic Fibrosis Society
- To be able to produce phlegm
Age in the registry: 8 years to 14 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bezmialem Vakif University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.